Published in G Ital Chemioter on October 27, 1978
Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene (2006) 4.85
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood (1998) 1.65
In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria. Antimicrob Agents Chemother (1994) 1.60
Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr (1998) 1.45
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia (2009) 1.45
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol (1997) 1.44
Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies. J Clin Microbiol (1988) 1.20
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol (2003) 1.13
Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol (2003) 1.12
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene (2006) 1.08
Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care (1996) 1.05
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol (2002) 1.05
Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis. J Pediatr (1983) 1.00
Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Int J Pharm (1999) 0.98
Expression of gene MAGE-A4 in Reed-Sternberg cells. Blood (2000) 0.96
Early immunisation with hepatitis B vaccine: a five-year study. Vaccine (2000) 0.96
A distinctive epitheliomesenchymal biphasic tumor in the duodenum: the first case of duodenoblastoma? Virchows Arch (2012) 0.95
Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol (2001) 0.93
Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations. Proc Natl Acad Sci U S A (1988) 0.93
Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol (1995) 0.92
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia (2005) 0.90
Tyrosinase gene expression in human tissues. Pigment Cell Res (1993) 0.89
Villous adenoma of the main pancreatic duct: a potentially malignant tumor? Am J Gastroenterol (1990) 0.89
The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells. Blood (2001) 0.87
t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Leukemia (2006) 0.87
Experimental infections for the evaluation of beta-lactamase resistance. Antimicrob Agents Chemother (1982) 0.87
PEG-Ara-C conjugates for controlled release. Eur J Med Chem (2004) 0.86
Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine (1998) 0.85
Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor. Hybridoma (1998) 0.85
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers. Pediatrics (1993) 0.84
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms. Br J Haematol (2001) 0.82
Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery. Biomaterials (1999) 0.82
The kinetics of cefuroxime in ascitic and pleural fluid. Int J Clin Pharmacol Ther Toxicol (1982) 0.82
Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center. Ann Oncol (1998) 0.82
Depression of homograft rejection and graft-versus-host reactivity following 7,12-dimethylbenz(a)anthracene exposure in the rat. Cancer Res (1971) 0.81
Study of diffusion of cefuroxime into middle ear effusions of patients with chronic purulent otitis media. J Antimicrob Chemother (1982) 0.81
Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides. Microbiologica (1991) 0.81
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med (2001) 0.81
In vitro activity of cefuroxime against Treponema pallidum and Neisseria gonorrhoeae. J Antimicrob Chemother (1980) 0.80
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor. Microbiologica (1991) 0.80
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma. Bone Marrow Transplant (2006) 0.80
Unrestricted T-cell receptor V-region gene repertoire in tumor-infiltrating lymphocytes from human breast carcinomas. Cancer (1993) 0.80
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users. New Microbiol (1993) 0.80
Caspases: conductors of the cell death machinery in lymphoma cells. Leuk Lymphoma (2001) 0.79
Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma. Histopathology (2000) 0.79
Study on the antibacterial activity of ceftazidime in an in vitro pharmacokinetic model. Drugs Exp Clin Res (1985) 0.79
Synergistic interaction of bactericidal drugs and a factor present in serum ultrafiltrate. Arzneimittelforschung (1981) 0.79
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. Pharmacology (1991) 0.79
New PEGs for peptide and protein modification, suitable for identification of the PEGylation site. Bioconjug Chem (2001) 0.78
Control of hepatitis B: evaluation of two different vaccinal schedules in newborns from HBsAg negative mothers. New Microbiol (1993) 0.78
Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine (1995) 0.78
Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient. Br J Haematol (2008) 0.78
Analysis of BAX expression in human tissues using the anti-BAX, 4F11 monoclonal antibody on paraffin sections. Pathol Res Pract (1998) 0.78
Lymphocyte functions in the rat spleen at various times after urethan administration. Tumori (1976) 0.78
Role of FGFs and FGF receptors in human carcinogenesis. Ann N Y Acad Sci (1991) 0.78
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1. Microbiologica (1989) 0.78
In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. J Control Release (2000) 0.78
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure. Microbiologica (1990) 0.78
Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41). Microbiologica (1991) 0.78
In-vitro activity of ofloxacin against Chlamydia trachomatis. J Chemother (1989) 0.77
In vitro activity of cefuroxime against Treponema pallidum. J Antimicrob Chemother (1978) 0.76
Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients. Histopathology (1999) 0.76
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. Microbiologica (1985) 0.76
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera. Microbiologica (1991) 0.76
Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.75
Low-grade rectal malt lymphoma occurring in a patient with chronic lymphocytic leukaemia. Br J Haematol (2002) 0.75
Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions. Mol Pathol (2001) 0.75
[Cefuroxime. Pharmacokinetic aspects in man after intravenous administration under different conditions]. G Ital Chemioter (1981) 0.75
[Cefuroxime: placental passage and concentrations in the uterus and adnexa uteri. Preliminary results]. Ann Ostet Ginecol Med Perinat (1981) 0.75
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1. Microbiologica (1990) 0.75
[In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics]. Boll Ist Sieroter Milan (1989) 0.75
Ofloxacin: therapeutic activity in experimental infections. Chemioterapia (1986) 0.75
[General criteria of evaluation of the efficacy of an antibiotic]. G Ital Chemioter (1977) 0.75
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers. Microbiologica (1991) 0.75
Human immunodeficiency virus (HIV): an ultrastructural study. Microbiologica (1987) 0.75
[Radiation protection in radiological departments and evaluation of doses absorbed by the personnel]. Radiol Med (1978) 0.75
Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis. Int J Clin Pharmacol Ther Toxicol (1982) 0.75
Mice infection with HIV-1: a new mouse model for HIV-1 in vivo research. Microbiologica (1992) 0.75
[Effect of calcium on natural resistance and various aspects of immunity. I. Role of calcium oleate in the stimulation of natural resistance to experimental staphylococcal infection]. Boll Ist Sieroter Milan (1974) 0.75
Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model. Chemioterapia (1986) 0.75
[Blood and urinary levels of methyl-, hydroxy-, desoxyadenosylcobalamin in the rabbit following parenteral administration of methylcobalamin]. Farmaco Prat (1972) 0.75
Cefuroxime concentrations in pericardial fluid. J Antimicrob Chemother (1981) 0.75
Pharmacokinetic studies of cefuroxime in patients with liver cirrhosis. Arzneimittelforschung (1982) 0.75
[Determination in time of the residual antibacterial activity after disinfection of hands with Citrosil products with benzalkonium chloride base]. Minerva Chir (1988) 0.75
Effect of non-steroidal antiinflammatory drugs on some biological activities dependent on complement activation. Arzneimittelforschung (1979) 0.75
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study. Microbiologica (1988) 0.75
[Pulmonary aspergillomas and pancreatic localization in disseminated aspergillosis]. Presse Med (1988) 0.75
Chemotherapy of toxoplasmic encephalitis in AIDS patients. J Chemother (1989) 0.75
[Cefuroxim. Importance of beta-lactamase resistance, evaluated in vitro and in vivo]. G Ital Chemioter (1981) 0.75
Tissue distribution and serum levels of cephalexin in man. Postgrad Med J (1970) 0.75
Ofloxacin: in vitro and in vivo activity. Chemioterapia (1987) 0.75
In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses. Chemioterapia (1984) 0.75